ABNB vs AEE Stock Comparison
Scores Breakdown
| Metric | ABNB | AEE |
|---|---|---|
| 📈 Growth | 14/30 | 8/30 |
| 💰 Profitability | 18/20 | 16/20 |
| 🏦 Financial Health | 16/20 | 12/20 |
| 💵 Valuation | 13/20 | 12/20 |
| ⚠️ Risk (lower is better) | 7/10 | 6/10 |
| Overall Score | 64/100 | 52/100 |
Side-by-Side Summaries
| ABNB Analysis | AEE Analysis |
|---|---|
📈 Growth & Financial TrajectoryOver 8 quarters, Revenue declined modestly from $3.732B in Q3 2024 to $3.608B in Q2 2026, while Net Income rose from $461M to $816M, with a peak of $1.374B in Q3 2025 before a mid-year dip. This shows profitability resilience amid revenue variability, driven by episodic operating leverage. Overall, the growth signal is modest on revenue but improving on bottom-line momentum into Q2 2026. 💰 Margins & Cash Flow
🛡️ Balance Sheet & Liquidity
⚠️ Key Drivers & Risks
|
📈 Growth & Financial TrajectoryOver 8 quarters, Revenue moved from about $2.17B (2024Q4) to a high of about $2.70B (2025Q3) and ended around $2.09B in 2026Q2. Net income (to parent) rose from about $207M (2024Q4) to roughly $314M (2026Q2), indicating improving profitability despite revenue swings. The trend shows volatility but a constructive late-cycle improvement with strong operating performance in several quarters. 💰 Margins & Cash FlowOperating margins have hovered in the low-to-mid 20s percent on average, with standout quarters in 2025Q1–Q2 (~32–34%) and weaker margins in 2024Q3–Q4 (~9–10%). Net cash from operating activities remained positive in all periods, including a peak near $0.96B (2025Q4); investing cash flow was consistently negative, reflecting capital intensity. Financing activity varied, contributing to liquidity in several quarters. 🛡️ Balance Sheet & LiquidityTotal Liabilities run in the mid-to-high $30s billions with equity around $12–14B, implying leverage near 2.5–3x. Long-term Debt remained substantial (roughly $18–20B across periods). Current assets ( ⚠️ Key Drivers & Risks
|